Cytek IPO Presentation Deck
Growing Market Needs Require Advanced Cell Analysis
8
Flow cytometry used in clinical
settings and provide new
possibilities for novel drug
development
The Rise of
Immuno-Oncology
8
Customers demand increased
access to high parameter flow
cytometry at both the high-end
and low-end entry points
Demands of
Flow Cytometry
Customers
are Increasing
DE
Market is characterized by large,
legacy players and a dearth of
innovation, thus there is a large
appetite for novel solutions
Opportunity to
Innovate a Market
Suffering from Inertia
The diagnostics sector has
enjoyed a period of significant
innovation, particularly within
the fields of genomics and
proteomics
Clinical
Diagnostics are
Changing
Drive adoption and application development of Cytek's FSP platform
25View entire presentation